KA
IDXX icon

Kintegral Advisory’s Idexx Laboratories IDXX Stock Holding History

Kintegral Advisory’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.68M Hold
5,087
– – 0.22% 107
2026
Q1 		$2.86M Sell
5,087
-226
-4% -$145K 0.27% 98
2025
Q4 		$3.59M Sell
5,313
-146
-3% -$99.4K 0.3% 84
2025
Q3 		$3.49M Sell
5,459
-24
-0.4% -$14.6K 0.3% 87
2025
Q2 		$2.94M Sell
5,483
-8
-0.1% -$3.83K 0.27% 98
2025
Q1 		$2.31M Sell
5,491
-19
-0.3% -$8.25K 0.23% 110
2024
Q4 		$2.28M Sell
5,510
-256
-4% -$112K 0.22% 117
2024
Q3 		$2.91M Sell
5,766
-76
-1% -$36.9K 0.27% 101
2024
Q2 		$2.85M Buy
5,842
+882
+18% +$443K 0.27% 99
2024
Q1 		$2.68M Sell
4,960
-15
-0.3% -$8.2K 0.27% 97
2023
Q4 		$2.76M Sell
4,975
-32
-0.6% -$15K 0.31% 91
2023
Q3 		$2.19M Sell
5,007
-3
-0.1% -$1.5K 0.27% 101
2023
Q2 		$2.52M Hold
5,010
– – 0.3% 96
2023
Q1 		$2.51M Sell
5,010
-269
-5% -$129K 0.32% 94
2022
Q4 		$2.15M Buy
5,279
+427
+9% +$166K 0.28% 106
2022
Q3 		$1.58M Hold
4,852
– – 0.22% 113
2022
Q2 		$1.7M Buy
4,852
+103
+2% +$42K 0.22% 107
2022
Q1 		$2.6M Buy
4,749
+106
+2% +$55.8K 0.29% 88
2021
Q4 		$3.06M Hold
4,643
– – 0.32% 78
2021
Q3 		$2.89M Hold
4,643
– – 0.34% 70
2021
Q2 		$2.93M Hold
4,643
– – 0.35% 70
2021
Q1 		$2.27M Hold
4,643
– – 0.29% 88
2020
Q4 		$2.32M Hold
4,643
– – 0.32% 79
2020
Q3 		$1.82M Sell
4,643
-149
-3% -$55.1K 0.28% 88
2020
Q2 		$1.58M Hold
4,792
– – 0.25% 95
2020
Q1 		$1.16M Buy
4,792
+537
+13% +$140K 0.23% 107
2019
Q4 		$1.11M Hold
4,255
– – 0.2% 128
2019
Q3 		$1.16M Hold
4,255
– – 0.23% 120
2019
Q2 		$1.17M Hold
4,255
– – 0.24% 119
2019
Q1 		$951K Buy
4,255
+2,081
+96% +$430K 0.2% 124
2018
Q4 		$404K Buy
+2,174
New +$446K 0.12% 150

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Kintegral Advisory's IDXX Position: Q2 2026 in Review

Kintegral Advisory held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 5,087 shares worth $2.68M. The position accounts for 0.22% of the portfolio, ranked #107.

Kintegral Advisory first reported a position in IDXX in Q4 2018 and has held it in 31 quarters since. The position peaked at $3.59M in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Kintegral Advisory held 5,087 shares of Idexx Laboratories worth $2.68M as of Q2 2026.
  • Kintegral Advisory left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up 0.22% of Kintegral Advisory's portfolio in Q2 2026, its #107 holding.
  • Kintegral Advisory first reported a position in Idexx Laboratories in Q4 2018 and has held it in 31 quarters since.
  • Kintegral Advisory's Idexx Laboratories position peaked at $3.59M in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Kintegral Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.